Insights Into Prostate Cancer

Perspectives on drivers in treatment decisions in the management of prostate cancer

Southwest – March 16, 2022

Faculty Chair

Scott Tagawa, MD, MS, FACP

Weill Cornell Medical Center, New York, NY

Central – March 23, 2022

Faculty Chair

Scott Tagawa, MD, MS, FACP

Weill Cornell Medical Center, New York, NY

Southeast – May 26, 2022

Faculty Chair

Scott Tagawa, MD, MS, FACP

Weill Cornell Medical Center, New York, NY

Northeast – August 20, 2022

Faculty Chair

Alicia Morgans, MD, MPH

Dana-Farber Cancer Institute

Midwest – September, 2022

Faculty Chair

TBC

TBC

Northwest – November 19, 2022

Faculty Chair

Evan Yu, MD

Fred Hutch Cancer Center

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Philadelphia, PA
  • Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Chicago, IL
  • Illinois, Iowa, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio

More Information

  • Seattle, WA
  • Northern California, Oregon, Washington, Idaho, Montana, Wyoming

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of prostate cancer
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone, and combinations of these drugs

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.